MyLRC +
SB 2 require prescribers to access the prescription drug monitoring pr...
State of South Dakota  
NINETY-SECOND SESSION
LEGISLATIVE ASSEMBLY, 2017  

619Y0016   SENATE BILL   NO.  2  

Introduced by:    Senators White, Bolin, and Monroe and Representatives Stevens, Haugaard, and Tieszen at the request of the Interim Substance Abuse Prevention Study Committee
 

        FOR AN ACT ENTITLED, An Act to require prescribers to access the prescription drug monitoring program database prior to issuing a prescription to certain controlled substances.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA:
    Section 1. That § 34-20E-11 be amended to read:
    34-20E-11. Nothing in this chapter requires a prescriber or dispenser to obtain information about a patient from the central repository prior to prescribing or dispensing a controlled substance. A prescriber, dispenser, or other health care provider may not be held liable in damages to any person in any civil action on the basis that the prescriber, dispenser, or other health care provider did or did not seek to obtain information from the central repository. Unless there is shown a lack of good faith, the board, a prescriber, dispenser, or any other person in proper possession of information provided under this chapter is not subject to any civil liability by reason of:
            (1)    The furnishing of information under the conditions provided in this chapter;
            (2)    The receipt and use of, or reliance on, such the information;
            (3)    The fact that any such of the information was not furnished; or
            (4)    The fact that such the information was factually incorrect or was released by the board to the wrong person or entity.
        Section 2. That chapter 34-20E be amended by adding a NEW SECTION to read:
    A prescriber shall review a patient's prescription drug record available through the program before the prescriber issues a prescription order for any controlled substance referenced in this chapter.
    Section 3. That chapter 34-20E be amended by adding a NEW SECTION to read:
    The requirement under section 2 of this Act does not apply if:
            (1)    The patient is receiving hospice care;
            (2)    The prescription is for a number of doses that is intended to last the patient three days or less and is not subject to refill;
            (3)    The monitored prescription is lawfully administered to the patient; or
            (4)    Due to emergency, the prescriber is unable to review the patient's records prior to issuing the prescription.
    Section 4. This Act is effective on July 1, 2018.